amoxicillin has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agard, C; Berthier, S; Bertolino, J; Cerles, O; Chaigne, B; Cosse, C; Dion, J; Diot, E; Fagedet, D; Giret, C; Granel, B; Jourde, W; Kernéis, S; Le Jeunne, C; Lescoat, A; Luque Paz, D; Martin, M; Maurier, F; Mouthon, L; Nguyen, C; Priollet, P; Pugnet, G; Raffray, L; Toquet, S; Truchetet, ME; Viallard, JF; Watelet, B | 1 |
| Goerz, G; Humfeld, S; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F | 1 |
2 other study(ies) available for amoxicillin and Sclerosis, Systemic
| Article | Year |
|---|---|
Osteitis in Systemic Sclerosis: A Nationwide Case-Control Retrospective Study.
Topics: Amoxicillin; beta-Lactamase Inhibitors; Case-Control Studies; Humans; Osteitis; Retrospective Studies; Scleroderma, Systemic; Skin Ulcer; Ulcer | 2022 |
Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication.
Topics: Adult; Aged; Amoxicillin; Breath Tests; Carbon Isotopes; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Risk Factors; Scleroderma, Systemic; Stomach Diseases; Urea | 1994 |